Vimarsana
Biggest News Aggregation in the World

Appalachian Pharm Processing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Appalachian Pharm Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Appalachian Pharm Processing Today - Breaking & Trending Today

Vext Announces Delay of Annual Filings and Postponement of Conference Call - Vimarsana News

Vext Announces Delay of Annual Filings and Postponement of Conference Call

Vext Science, Inc. , a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, announces that its annual financial statements for the year ended December 31, 2023, the related...

Vext Announces Close of Ohio Acquisition, Solidifying its Vertically Integrated Position in the State - Vimarsana News

Vext Announces Close of Ohio Acquisition, Solidifying its Vertically Integrated Position in the State

Vext Science, Inc. , a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it has completed the previously announced acquisition of Appalachian Pharm...

Vext Science Q2 Revenue Grows 4.8% YoY, What About Income? - Vext Science (OTC:VEXTF) - Vimarsana News

Vext Science Q2 Revenue Grows 4.8% YoY, What About Income? - Vext Science (OTC:VEXTF)

Vext Science, Inc. (OTCQX: VEXTF) (CSE:VEXT) released its financial results for the period ended June 30, 2023, revealing revenue of $9.2 million, an increase of 4.8% compared to $8.8 million in Q2 2022, and an increase of 0.8% compared to $9.1 million in Q1 2023.

Vext Announces Financial Results for Q1 2023 - Technical420 - Vimarsana News

Vext Announces Financial Results for Q1 2023 - Technical420

Technical420 is dedicated to educating investors about the risk and rewards of investing in the cannabis industry. We highlight companies that have the most growth potential by utilizing our proprietary analytics platform.

VEXT Science, Inc.: Vext Announces Financial Results for Q1 2023 - Vimarsana News

VEXT Science, Inc.: Vext Announces Financial Results for Q1 2023

Revenue of $9.1 million, Adjusted EBITDA of $2.9 million, Adjusted EBITDA Margin of 32%.Generated positive EBITDA of $1.6 million.Expanded retail footprint through the acquisition of Jackson, Ohio dispensary